SERA PROGNOSTICS, INC. Shares Outstanding (Cover Page)
SERA PROGNOSTICS, INC. (SERA) had Shares Outstanding (Cover Page) of 29.29 million shares as of 2021-08-25, per its 10-Q filed 2021-08-30.
Discontinued › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2021-08-30
- 2021-08-25: Entity Common Stock, Shares Outstanding 29.29M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2021-08-25 | 29.29M shares 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |